Home » Authors » Anette Breindl

Articles by Anette Breindl

In Very Early Going, Killing Cancer Cells Indiscriminately

March 16, 2005

By Anette Breindl

New Insights Into Neurons, Their Autism Balancing Act

March 11, 2005

By Anette Breindl

New Insights Into Neurons, Their Autism Balancing Act

March 11, 2005

By Anette Breindl

Antibody Affinity Maturation Moves From Animal To Tube

March 9, 2005

By Anette Breindl

Antibody Affinity Maturation Moves From Animal To Tube

March 9, 2005

By Anette Breindl

Gene Therapy Heals Cells, Hearing In Deaf Guinea Pigs

March 7, 2005

By Anette Breindl

Gene Therapy Heals Cells, Hearing In Deaf Guinea Pigs

March 7, 2005

By Anette Breindl

In CF, Smaller Promoter Makes A Better Gene Therapy Vehicle

March 1, 2005

By Anette Breindl

In CF, Smaller Promoter Makes A Better Gene Therapy Vehicle

March 1, 2005

By Anette Breindl

Aggressive HIV Strain: Assay Possibilities, Case Study Limits

Feb. 28, 2005

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...